$2.27T
Total marketcap
$122.08B
Total volume
BTC 50.24%     ETH 15.68%
Dominance

Shanghai Hile Bio-Technology Co., Ltd. 603718.SS Stock

8.2 CNY {{ price }} -3.415783% {{change_pct}}%
COUNTRY
China
Exchange
Shanghai
Market Cap
5.39B CNY
LOW - HIGH [24H]
7.94 - 8.52 CNY
VOLUME [24H]
4.5M CNY
{{ volume }}
P/E Ratio
34.16
Earnings per share
0.24 CNY

Shanghai Hile Bio-Technology Co., Ltd. Price Chart

Shanghai Hile Bio-Technology Co., Ltd. 603718.SS Financial and Trading Overview

Shanghai Hile Bio-Technology Co., Ltd. stock price 8.2 CNY
Previous Close 9.34 CNY
Open 9.34 CNY
Bid 9.39 CNY x 0
Ask 9.41 CNY x 0
Day's Range 9.34 - 9.43 CNY
52 Week Range 9 - 12.61 CNY
Volume 2.25M CNY
Avg. Volume 3.52M CNY
Market Cap 6.05B CNY
Beta (5Y Monthly) 0.871917
PE Ratio (TTM) 46.999996
EPS (TTM) 0.24 CNY
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date July 1, 2021
1y Target Est N/A

603718.SS Valuation Measures

Enterprise Value 5.9B CNY
Trailing P/E 46.999996
Forward P/E 37.6
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 21.155653
Price/Book (mrq) 5.322763
Enterprise Value/Revenue 20.617
Enterprise Value/EBITDA 113.138

Trading Information

Shanghai Hile Bio-Technology Co., Ltd. Stock Price History

Beta (5Y Monthly) 0.871917
52-Week Change -17.19%
S&P500 52-Week Change 20.43%
52 Week High 12.61 CNY
52 Week Low 9 CNY
50-Day Moving Average 10.28 CNY
200-Day Moving Average 10.59 CNY

603718.SS Share Statistics

Avg. Volume (3 month) 3.52M CNY
Avg. Daily Volume (10-Days) 3.15M CNY
Shares Outstanding 644M
Float 287.13M
Short Ratio N/A
% Held by Insiders 59.40%
% Held by Institutions 1.04%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0.057
Trailing Annual Dividend Yield 0.61%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 23:10

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 43.77%
Operating Margin (ttm) 5.23%
Gross Margin 59.23%
EBITDA Margin 18.22%

Management Effectiveness

Return on Assets (ttm) 0.56%
Return on Equity (ttm) 10.74%

Income Statement

Revenue (ttm) 286.15M CNY
Revenue Per Share (ttm) 0.45 CNY
Quarterly Revenue Growth (yoy) -16.30%
Gross Profit (ttm) 176.9M CNY
EBITDA 52.14M CNY
Net Income Avi to Common (ttm) 125.25M CNY
Diluted EPS (ttm) 0.2
Quarterly Earnings Growth (yoy) 34.39%

Balance Sheet

Total Cash (mrq) 321.14M CNY
Total Cash Per Share (mrq) 0.5 CNY
Total Debt (mrq) 235.63M CNY
Total Debt/Equity (mrq) 21.28 CNY
Current Ratio (mrq) 2.194
Book Value Per Share (mrq) 1.766

Cash Flow Statement

Operating Cash Flow (ttm) 308.63M CNY
Levered Free Cash Flow (ttm) 228.34M CNY

Profile of Shanghai Hile Bio-Technology Co., Ltd.

Country China
State N/A
City Shanghai
Address Economic Development Zone
ZIP 201403
Phone 86 21 6089 0888
Website https://www.hile-bio.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 491

Shanghai Hile Bio-Technology Co., Ltd. researches, develops, produces, and sells veterinary biological products for livestock and poultry in China. The company offers swine fever live vaccines; trivalent inactivated vaccines for piglets; inactivated vaccine for streptococcus suis; pseudorabies live vaccines; inactivated oil emulsion vaccine of porcine parvovirus disease; pathogenic porcine reproductive and respiratory syndrome live vaccines; transmissible gastroenteritis, porcine epidemic diarrhea, and porcine rotavirus triple live vaccines; porcine reproductive and respiratory syndrome live vaccines; swine transmissible gastroenteritis and swine epidemic diarrhea combined inactivated vaccines; porcine circovirus type 2 inactivated vaccines; and swine Japanese encephalitis live vaccines. It also provides chicken infectious bursal disease live vaccines; inactivated avian infectious rhinitis vaccines; newcastle disease and avian influenza combined inactivated vaccines; newcastle disease, infectious bronchitis, egg drop syndrome, and avian influenza quadruple inactivated vaccines; avian influenza inactivated vaccines; newcastle disease, infectious bronchitis, and avian influenza triple inactivated vaccines; avian infectious bronchitis live vaccines; avian newcastle disease and avian infectious bronchitis combined live vaccines; newcastle disease low virulent live vaccines; Marek's disease turkey herpes virus live vaccines; and fowlpox live vaccines. The company was founded in 1981 and is based in Shanghai, China.

Q&A For Shanghai Hile Bio-Technology Co., Ltd. Stock

What is a current 603718.SS stock price?

Shanghai Hile Bio-Technology Co., Ltd. 603718.SS stock price today per share is 8.2 CNY.

How to purchase Shanghai Hile Bio-Technology Co., Ltd. stock?

You can buy 603718.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Shanghai Hile Bio-Technology Co., Ltd.?

The stock symbol or ticker of Shanghai Hile Bio-Technology Co., Ltd. is 603718.SS.

Which industry does the Shanghai Hile Bio-Technology Co., Ltd. company belong to?

The Shanghai Hile Bio-Technology Co., Ltd. industry is Biotechnology.

How many shares does Shanghai Hile Bio-Technology Co., Ltd. have in circulation?

The max supply of Shanghai Hile Bio-Technology Co., Ltd. shares is 657.9M.

What is Shanghai Hile Bio-Technology Co., Ltd. Price to Earnings Ratio (PE Ratio)?

Shanghai Hile Bio-Technology Co., Ltd. PE Ratio is 34.16666800 now.

What was Shanghai Hile Bio-Technology Co., Ltd. earnings per share over the trailing 12 months (TTM)?

Shanghai Hile Bio-Technology Co., Ltd. EPS is 0.24 CNY over the trailing 12 months.

Which sector does the Shanghai Hile Bio-Technology Co., Ltd. company belong to?

The Shanghai Hile Bio-Technology Co., Ltd. sector is Healthcare.